No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ORIC250117P5000
- 0.05
- 0.000.00%
15min DelayClose Dec 27 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume22 Open Interest5.00Strike Price0.00Turnover137.52%IV40.00%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0414Delta0.0336Gamma165.00Leverage Ratio-0.0058Theta-0.0002Rho-6.83Eff Leverage0.0017Vega
Intraday
- 5D
- Daily
News
We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
Citi Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Cuts Target Price to $13
Citi Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC)
Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $15
Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $20
JonesTrading Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $17